Miochol-E 10 mg/ml jauhe ja liuotin instillaatioliuosta varten, silmän sisään Suomi - suomi - Fimea (Suomen lääkevirasto)

miochol-e 10 mg/ml jauhe ja liuotin instillaatioliuosta varten, silmän sisään

dr. gerhard mann chem.-pharm. fabrik gmbh - acetylcholine chloride - jauhe ja liuotin instillaatioliuosta varten, silmän sisään - 10 mg/ml - asetyylikoliini

URECHOLINE CHLORID 5 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

urecholine chlorid 5 mg tabletti

merck & co. inc. - bethanecholi chloridum - tabletti - 5 mg - betanekoliini

URECHOLINE 5 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

urecholine 5 mg tabletti

merck sharp & dohme b.v. - bethanecholi chloridum - tabletti - 5 mg - betanekoliini

Yselty Euroopan unioni - suomi - EMA (European Medicines Agency)

yselty

theramex ireland limited - linzagolix choline - leiomyoma - aivolisäkkeen ja hypotalamuksen hormonit ja analogit - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

Ultomiris Euroopan unioni - suomi - EMA (European Medicines Agency)

ultomiris

alexion europe sas - ravulizumab - hemoglobinuria, paroxysmal - selektiiviset immunosuppressantit - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.

Prazitel Plus 50 mg / 144 mg / 150 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

prazitel plus 50 mg / 144 mg / 150 mg tabletti

chanelle pharmaceuticals manufacturing limited - febantel, praziquantel, pyrantel embonate - tabletti - 50 mg / 144 mg / 150 mg - pratsikvanteeli

Vyvgart Euroopan unioni - suomi - EMA (European Medicines Agency)

vyvgart

argenx - efgartigimod alfa - myasthenia gravis - immunosuppressantit - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Proline Suomi - suomi - Fimea (Suomen lääkevirasto)

proline

bayer ag - tiabendazolum - annosjauhe - tiabendatsoli

Proline Xpert Suomi - suomi - Fimea (Suomen lääkevirasto)

proline xpert

bayer ag -

Exproline vet 50 mg paikallisvaleluliuos Suomi - suomi - Fimea (Suomen lääkevirasto)

exproline vet 50 mg paikallisvaleluliuos

krka, d.d., novo mesto - fipronil - paikallisvaleluliuos - 50 mg - fiproniili